A clinical roadmap for base and prime editing
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Hemoglobinopathies and Related Disorders · Genomics and Rare Diseases
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (10)
Show source-provided references
1. Locatelli, F. et al. Exagamglogene autotemcel for transfusion-dependent β-thalassemia. N. Engl. J. Med. 390, 1663–1676 (2024).10.1056/NEJMoa2309673 ↗
2. Frangoul, H. et al. Exagamglogene autotemcel for severe sickle cell disease. N. Engl. J. Med. 390, 1649–1662 (2024).10.1056/NEJMoa2309676 ↗
3. Frangoul, H. et al. CRISPR-Cas9 gene editing for sickle cell disease and β-thalassemia. N. Engl. J. Med. 384, 252–260 (2021).10.1056/NEJMoa2031054 ↗
4. Cohn, D. M. et al. CRISPR-based therapy for hereditary angioedema. N. Engl. J. Med. 392, 458–467 (2025).10.1056/NEJMoa2405734 ↗
5. Pierce, E. A. et al. Gene editing for CEP290-associated retinal degeneration. N. Engl. J. Med. 390, 1972–1984 (2024).10.1056/NEJMoa2309915 ↗
6. Pacesa, M., Pelea, O. & Jinek, M. Past, present, and future of CRISPR genome editing technologies. Cell 187, 1076–1100 (2024).10.1016/j.cell.2024.01.042 ↗
7. Abou-el-Enein, M. The fate(s) of CAR T-cell cherapy: navigating the risks of CAR+ T-cell malignancy. Blood Cancer Discov. 5, 249–257 (2024).10.1158/2643-3230.BCD-23-0272 ↗
8. Musunuru, K. et al. Patient-specific in vivo gene editing to treat a rare genetic disease. N. Engl. J. Med. 392, 2235–2243 (2025).10.1056/NEJMoa2504747 ↗
9. Cadinanos-Garai, A. et al. High-dimensional temporal mapping of CAR T cells reveals phenotypic and functional remodeling during manufacturing. Mol. Ther. 33, 2291–2309 (2025).10.1016/j.ymthe.2025.04.006 ↗
10. Mackall, C. L. et al. Enhancing pediatric access to cell and gene therapies. Nat. Med. 30, 1836–1846 (2024).10.1038/s41591-024-03035-1 ↗